A key event in the pathogenesis of Castleman's disease has been recently suggested to be and abnormal production of a B cell growth factor such as IL-6 (Interleukin 6), leading to lymphoproliferation and plasma cell differentiation and being involved in the pathogenesis of plasmacytomas. This evidence concerns the gene IL6 and plasmacytoma.